Structural Features of Clostridium botulinum Neurotoxin Subtype A2 Cell Binding Domain

Area of Science:

• Biochemistry
• Structural Biology
• Neuroscience

Background:

• Botulinum neurotoxins (BoNTs) are potent neurotoxins causing botulism but also used therapeutically.
• Different BoNT serotypes and subtypes exhibit varying toxicological profiles and potencies.
• BoNTs possess distinct domains: cell-binding, translocation, and catalytic.

Purpose of the Study:

• To determine the crystal structures of the botulinum neurotoxin A2 (BoNT/A2) cell-binding domain.
• To analyze the complex of BoNT/A2 cell-binding domain with its receptor, ganglioside GD1a.
• To provide a comprehensive structural analysis of BoNT/A2 receptor binding.

Main Methods:

• X-ray crystallography was employed to obtain structures at high resolution (1.63 Å and 2.10 Å).
• Structural analysis focused on the BoNT/A2 cell-binding domain alone and in complex with GD1a.
• Comparative analysis was performed with the previously reported BoNT/A2:SV2C structure.

Main Results:

• The crystal structure of the BoNT/A2 cell-binding domain complexed with ganglioside GD1a was determined.
• A potential redox-dependent Lys-O-Cys bridge near the ganglioside binding site was identified.
• A hinge motion between the H_CN and H_CC subdomains was observed.

Conclusions:

• The identified structural features provide insights into the mechanism of BoNT/A2 binding to its receptor.
• Understanding these interactions can inform the development of BoNT-based therapeutics.
• Further structural studies enhance the comprehension of BoNT/A2's toxicological and therapeutic properties.